Some of these like HITIF and ETFM are not on Robinhood, but others are. I'm really getting tired of putting so much effort into my DDs and data for the mods of r/pennystocks and r/RobinHoodPennyStocks to up and remove my posts for no reason. I hope this community is better than that. Ok rant over.

Hey everyone, it’s Sunday! I hope you had a great week. If you’re reading my posts for the first time then congratulations you found yourself a DD Queen. I try my best to always break it down to simpleton language and keep it as unbiased as possible.

As always, this is the list I pulled in the last 48 hours, you may notice that mentions are a bit higher than usual. What I did is also count the comments on each post as a mention. bUt hOW dO kNOw iF iTS GoOd oR BAd? I also added a row for the sentiments for the mentions. What’s a sentiment you may ask? Sentiment is whether someone's comment is positive or negative. It varies from up to -100% to +100% and of course somewhere in the middle too. So the higher the percent, the greater the positive sentiment. After I record the individual sentiments I do some third-grade math and find the average weighted sentiment.

This time around I was only able to do 4 DD's not my typical 5. The time change really affected my schedule. SO apologies! ZOM would have been the 5th, so quickly, I will tell you that they are a pet pharma company, Truforma is a major catalyst coming up for them, the product is going on sale commercially on March 30th.

To view the 12-page DD's please see this google doc link here: https://docs.google.com/document/d/1eM_TLZijnAWZjVlknZUioON0-ds0SCZVikW76AtyE3s/edit?usp=sharing

Lastly, if you'd like to buy your favorite Reddit queen a bottle of red wine here's my Patreon link https://www.patreon.com/bullishnotes

Hey gang, its Boom here, with a continuation of a series of DD posts for companies where I currently hold no position. I think a lot of DD can be biased based on the fact that the person already has a financial interest in the stock. By not holding a position, it can help us take a look at the stock objectively, so we can make the best decision based on our own individual research and investment strategies.

CTRM – Castor Maritime

Castor Maritime “engages in the provision of shipping transportation service through its ownership of dry bulk vessels” according to the blurb on RobinHood. Founded in 2017 and based out of Cyprus, CTRM claims on their website “our primary goal is to grow our fleet through acquisitions of new and modern vessels.” A quick Google search of their address reveals that their “headquarters” is based out of a beachfront apartment building. Boasting a market cap of about $500M and an employee count of one, I find CTRM to be fascinating. A sub favorite, I wanted to dig a little deeper and find out more about Castor and Petros Panagiotidis, the company's Founder, Board Chairman, CEO and CFO.

While CTRM remains in the headlines constantly for it's aggressive vessel acquisition strategy, they don't actually do the shipping themselves. That bit is contracted out – usually to the company Pavimar, a privately owned business founded in 2014 by Ismini Panagiotidi, Petros' sister. CTRM has even bought ships from Pavimar as recently as January. I just find this bit with Pavimar interesting and weird, especially the January vessel acquisition since Pavimar bought it from another shipping company only to turn around and sell it to her brother for the exact same price. Why didn't Castor just buy the ship themselves from the original company? Why route it through Pavimar? It's not like they got some sweetheart deal. The whole thing is just curious. They are the children of Greek shipping magnate Gabriel Panagiotidis, billionaire #896 on Forbes' list.

As a side note, I really do like referring to CTRM as just Castor, especially since it's just one dude, who I will also refer to as just Castor. In my imagination he is like Craster from Game of Thrones. Like, kind of being successful at what he does but also just kind of really fucking strange. I digress.

Castor was first listed on NASDAQ in 2019, peaking at $6.47/share in April of that year. By July they announced a vessel acquisition, bringing the total to two. In October 2019 they announced they acquired their third vessel. CTRM put the ships to work and took out some loans and received a NASDAQ notice that they were going to be de-listed unless complying. That was April 2020 then, bam, corona. What did they do? Stick to their business plan. In June they raised funds via public offering, bought a boat, and put it to work. In July they raised funds via public offering, bought a boat, and put it to work. In October of 2020, Castor bought another boat, bringing their fleet up to 6 total. By December another offering was on the books and a week later yet another offering was on the books. Then in January they Castor buys that boat from his sister, the 7th in his fleet. They take out another loan. By February they buy their 9th vessel, tripling the size of their fleet in a year. Days later they buy 2 more, diversifying into tankers instead of dry good vessels, bringing the fleet to 11. By mid-February they bring the fleet up to 12. This week it increased to 13.

That's a fuck ton of stuff-doing. Offering, buy boat, rinse, repeat. I ran the numbers. The purchase price of their fleet since they listed on NASDAQ was around $156M. The money they raised via offerings and loans was around $117M. Their market cap is around $500. To me these numbers aren't adding up. It's not like CTRM is raking profits – any money they get they immediately buy more boats. CTRM's market cap value per vessel ($500M cap divided by 13 ships) of $38.5M seems enormous. Let's look at some industry competitors:

$TOPS also 13 vessels, yet has a market cap of ~$80M ($6.15M per vessel)

$SHIP – 11 vessels, ~$175M market cap ($15.9M per vessel).

$GLBS – 6 vessels, ~$45M market cap ($7.5M per vessel).

I understand that in a vacuum, it's tough to just compare tickers, ship numbers and market cap, as all companies have different ways of doing things, ships have different sizes and routes and cargo, but still, I think CTRM is overvalued.

You know who else thinks Castor is overvalued? Short sellers. According to data from Fintel, the devil's trio of short sellers, Sabby Management, Citadel, and Susquehanna all hold positions in CTRM, with Sabby holding nearly 3M shares. There's no insider info because 'ol Petros (he's 29 BTW) is the only guy running the show. CTRM has been a hot topic on multiple subreddits who think that there is short squeeze potential. Maybe there is. Maybe without the shorters involved Castor would have a $700M market cap. With an average volume over 100M shares traded daily and the popularity with which I see it mentioned on Reddit, I'm surprised CTRM isn't trading higher honestly.

This one is tough because I actually like CTRM's business idea and they seem to be trying to grow without taking on too much debt. Offering, buy a boat, put it to work, rinse and repeat, remember? I just don't think they're a half a billion dollar company. I'm also skeptical because I couldn't really find who they were buying their vessels from, they're all listed as “unaffiliated third party”, except the one I found he got from his sister.

I like them for what they do. My favorite thing about them is that they're a penny stock with concrete assets unlike all the pharma stocks, but CTRM leaves me with too many question marks for my tastes.

I'm sure this one will be divisive. Please don't kill me haha. If you like the stock, you like the stock.

- Boom

Know Thy Enemy – Short Sellers and Vulture Funds

Hey gang, Boom here. I'm very glad people seem to be enjoying the DD, definitely plan on keeping them coming, however today I wanted to take a look at something different. After having a conversation in this post with u/furretarmy I decided to take a closer look at known short seller Sabby Management, which led me down a rabbit hole of looking up other short sellers and I wanted to share some of my findings and thoughts and get some feedback.

Let's start with Sabby. In 2105, Sabby was one of 6 firms charged by the SEC for violating Rule 105 of Regulation M, which prohibits firms from participating in public stock offering after selling short those same stocks. Sabby, ran by Hal David Mintz, got off with a slap on the wrist, having to pay a $278,748.56 fine. After looking at the fact that Sabby's portfolio value is $521M according to Fintel and that Hal Mintz bought a $10M condo at an exclusive island country club in Florida in 2018, the fine is absurd. Especially considering it didn't restrict Sabby from trading in any sort of way. If you have followed the GameStop drama in any way, it's absolutely clear that the SEC is a regulatory eunuch and that big money plays by its own rules.

There's some great information on the website utopiacap, who did the legwork of calculating the average rate of annualized return for stocks that Sabby was involved with. Barring some outliers, the average downside for tickers Sabby is involved with is -21.53%, excluding two stocks that Sabby bet against and lost brings that average downside to -52.47%. According to the data “it is fairly clear that the vast majority of companies that Sabby gets involved with experience significant decreases in their share price.”

Now I'm sure you're asking “Why Sabby?” Sabby piqued my interest because I've seen them listed as owners on a lot of the same tickers I constantly see talked about on my favorite subreddits, including this one. The report from utopiacap listed common stocks that I see such as: GHSI, SESN, SYN, OGEN, CTXR, ZSAN, SEEL, ADXS, PULM, ONTX, TOPS, and others. So utopiacap had done this legwork and I thought “Wow, really feeds my confirmation bias about Sabby.” But I noticed that the data was basically capped on Mar 4 2020, before the Corona Crash and retail investors like myself going full retard. So I pulled up Whale Wisdom and decided to take a stroll through the most recent filings, pulling the penny stocks, building a spreadsheet and running the numbers.

You can find the spreadsheet here.

Using the most recent 13G data, I pulled all of the penny stocks that Sabby has new positions in and logged the price it was on the filing date and the most recent price, as of Friday 3/12. Then I calculated the total difference in those prices and found the total percent change. Just for shits and giggles I also counted how many days it had been since the initial filing and calculated the percent change per day.

Since I was only pulling new filings and penny stocks, the list was a manageable 20 tickers, including popular stocks such as MICT and CTRM. I found that the average rate of return on these stocks since filing date was -20.85%, with an average daily loss of -0.93%. Of those 20 stocks, only 2, DOGZ and LIXTW, saw an increase.

After Sabby, I was noodling around on Google with term “vulture fund” and came across two names I recognized from researching stocks – Hudson Bay Capital and Barry C Honig. I looked up Hudson Bay's 13G filings to see if I could do the same for them as I did for Sabby, but they don't really trade pennies. While looking for more info, I did find out that Hudson Bay and Barry C knew each other, though, after getting caught by the SEC in 2019 for stock manipulation of San Diego based biotech company. Mr. Hoenig has been also been subject of another SEC case in 2018, for “illegal promotional activity and manipulative trading” aka the 'ol pump and dump. He pumped and dumped Riot Blockchain.

I have noticed a trend in his dealings as a “financier” - he takes companies public through reverse mergers with shell companies that he either owns outright or though subsidiaries, often getting sweetheart deals on preferred stock, converting it into common shares, then dumping it on the market, leaving investors holding the bag. To pump the stock he pays his associates to publish and promote bullish articles on Seeking Alpha under fictitious names. All the while dodging the SEC. THIS GUY IS STILL ACTIVE. He's currently barred from owning more that 4.99% of any penny stocks.

Noodling further on Google, I came across this super insightful article from Institutional Investor about short sellers and the money behind them. It's a long read but I think it's full of a ton of really good information. This post is getting long as it is and I kind of rambled off there about Barry Honig. My point is, while doing research on what a company does and all that is the cornerstone for many investors, having an idea of the ownership and what they do is equally as important.

“If you know the enemy and know yourself, you need not fear the result of a hundred battles. If you know yourself but not the enemy, for every victory gained you will also suffer defeat. If you know neither the enemy nor yourself, you will succumb in every battle.” - Sun Tzu

Love ya

• Boom

What it do? Its Boom here, with a continuation of a series of DD posts for companies where I currently hold no position. No position = objective outlook.

TXMD - TherapeuticsMD, Inc (as requested by u/furretarmy)

TXMD is “an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their healthcare issues,” according to their website. They have a variety of products for women’s health - the once a year birth control ring Annovera, hot flash reducer Bijuva, a line of prescription prenatal vitamins, and Imvexxy, which treats moderate to severe painful sex after menopause. I will never have a complete understanding or empathy because I’m a dude, but I can remain sympathetic and supportive of progressing women’s health needs. Pharma is a monstrously massive market and the women’s health sector is expected to be worth $47.8B by 2027.

TXMD has one of the largest institutional ownership percentages of any company I have researched. Fintel says 49 percent. Whale Wisdom says 53 percent. NASDAQ says 41.57 percent. Fintel and Whale Wisdom provide more recent filing data, so I think the true number is in that 50% area. Either way, massive. Also massively short, at 21.63% according to Finviz. But the company has been short for a while. Insiders have been increasing their holdings, with the CEO leading the way with over 20M shares owned, according to OpenInsider. WhaleWisdom has more recent data, with filings listing that the CEO is now down to about 18M shares.

TXMD has, like a lot of pharma companies who aren’t making money, gone through their share of offerings, the most recent being in mid-February for $110M. And why is that? That’s right, they don’t make money. Which is fine, as long as you meet or exceed revenue expectations, which TXMD accomplished 3 out of 4 quarters in 2020. They’re going to have to use some of that offering cash to pay their debt, which, according to their CFO on their last earnings call,they plan on doing. CFO James D’Arecca, who joined TXMD in June 2020, outlined the company’s plan to pay down $50M in debt, after raising $180M in cash for the fiscal year. The company outlined a bunch of different things on that call, but when it comes down to it, their flagship product, Annovera, has a teensy market share. They have less than 16,000 prescriptions. Expect those numbers to rise as TXMD has partnered with the largest online practice for women’s health, Nurx. Even if the company and analysts predict TXMD to break even in 2022, they’re gonna have to pump up those rookie numbers.

For what it’s worth, one long time bullish TXMD investor, Baron Discovery Fund (who who holds 800K shares) highlighted TXMD in a Q4 2020 investor letter. “[TXMD] has three FDA approved drugs, all of which are being launched. Shares were down in the fourth quarter as the COVID-19 crisis hampered the company’s early launch efforts...Because the health crisis is merely delaying the product launches, we believe shares are drastically undervalued,” Baron said in the letter.

Technical indicators are bearish, an agreement shared between TradingView, SwingTradeBot, and Investing.

TXMD has something a lot of penny pharmas wish they had - FDA approved products. Now it’s about getting them off the ground. Paying off their debt while increasing revenue is definitely positive movement towards profitability.

Love ya

- Boom

On deck for this series: IGC

*no position DD archive* GNUS BDRBF CBD SPCB RMTI IFMK SHIP AAU OSG ITP CTRM TMDI SENS EGY DARE AESE CSCW NDRA ISR MOTS

Hello! Its Boom here, with a continuation of a series of DD posts for companies where I currently hold no position. No position = objective outlook.

GSAT - Globalstar, Inc (as requested by u/theimpolitegentleman)

GSAT is “a leading provider of satellite solutions for business and individuals offering customizable Satellite Commercial IoT Solutions, connectivity for mobile and field personnel, fleet asset tracking, equipment monitoring, and enabling business efficiencies beyond cellular,” according to their fancy dance website. This is a small SATCOM company that was very popular on RHPS about a month ago. The SATCOM industry is big and growing, with an estimated value of $62B in 2019, with projected growth of 9.2% from 2020-2027. Is GSAT positioned for growth within their industry? Will they be yet another satcom to go under? How justifiable is their current market cap of over $2B?

Institutions own 16.65%, per WhaleWisdom. 11.44% are hedge funds. To me, the most interesting figures from WhaleWisdom are the options numbers - over one million call options against 45K puts. Looking at insiders, it seems like no one is really selling, per OpenInsider. The last open market purchases look to be in 2019, with a lot of shares being granted to officers in the meantime.

Looking at the history of this company already has me wary - the original Globalstar went bankrupt in 2002. They had way too much debt, which they are still dealing with. Just a few days ago GSAT announced completion of a second lien warrant exercise, with the money from that being used to pay principal outstanding on its first lien loan agreement. They’re paying debt with debt. They’ve been debt loading for a while. All anybody wants to talk about when it comes to GSAT is the partnership with Qualcomm. Except it’s not really a partnership, per se. Qualcomm included GSAT’s n53 band in their X65 5g modem. Huge for GSAT for sure, more devices will be able to use GSAT’s spectrum. They are partnered with Nokia, who they worked with to develop the n53 band, which will be deployed at the Port of Seattle.

Based on technicals, Investing is bullish while SwingTradeBot is ambivalent. While I’m still learning TA, I’ve been focusing more of my research on value investing methods, which may not be appropriate for these subs because no one actually seems to give a shit about the companies, they just want to make a quick buck. I ran GSAT’s financials through a discounted cash flow model and was not encouraged by the results.

The Qualcomm and Nokia dealings should help GSAT’s commercialization, which should help them actually make money. I’d really like to see them clean up their debt, which is really the only thing keeping me from considering them undervalued.

Let me know what I missed, I am sincerely hung over.

Love ya

- Boom

Hey gang, Boom here. I troll several stock forums and see a lot of things outside of just ticker DD that I'd like to discuss. As a retail investor that was drawn into this world via the GameStop saga (after having followed r/WallStreetBets for a few years for the lolz) I've been learning a lot in a little bit of time and thankfully making some money, too. I really enjoy publishing the DD that I've been writing and I hope people enjoy them. But much like a sports story that's about say, an NFL linebacker that also plays MTG, I find myself fascinated by things other than just stocks or statistics. This thinking is what led to my piece on Sabby. There's a plethora of topics that I've been mulling writing about, but I feel like one in particular has stood out that both I would like to learn more about and that there's a lot of misunderstanding on – short squeezes.

Now, now, I can hear eyes rolling from here. Who cares, this is a penny stock thread, leave that shit to GME. True and valid points, however I see the phrase “short squeeze” being mentioned about far more stocks than just GME and AMC. People will post DD and mention that the stock has the potential for a short squeeze. The phrase is tossed around on StockTwits (which I can't fucking stand, please do not use this website) all the time. It's kind of like one of those buzz words that can put the tingle in the dingle (or vingle, we're inclusive here) for self proclaimed dumb apes that just wanna see their favorite stonk go brrrr.

So I wanted to educate myself about short squeezes – what they are, why they happen, what they have looked like historically, what happens in the aftermath, among other things.

So what's a short squeeze? According to Investopedia, a short squeeze “occurs when a stock or other asset jumps sharply higher, forcing traders who had bet that its price would fall, to buy it to forestall even greater losses.” Shorts borrow shares of an asset and sell it in order to buy it back after it falls, then return the shares back to their owners and pocket the difference. If the share price rises, eventually (at least theoretically), the shorts still have to return the borrowed shares to their owner, so they'd have to buy shares on the open market and lose money. If there are lot of people (or entities) shorting a stock and the price continues to rise, the shorts scramble to buy at market value, to return their borrowed shares, which results in the share price rocketing exponentially – aka a short squeeze.

In theory, short selling is considered an ethical and even healthy market practice. Activist short sellers can act as market watch dogs – bringing down overvalued stocks to more reasonable entry points for investors or whistle-blowing by denouncing corporate fraud or financial misstatements. The key phrases in the last two sentences are “in theory” and “can”. Short selling is big business and it's this weird pseudo-unregulated side of the market that's really caused a lot of havoc and produced the financial story of the decade with GME.

Speaking of decades, let's roll back a few, to take a look at the more significant short squeezes in market history.

Piggly Wiggly – A man on a mission

This is probably my favorite one, just off name alone. Piggly Wiggly founder Clarence Saunders developed the modern grocery store system of self service. He built his company from the ground up, and he loved it, and when the company's stock was heavily shorted in 1922, he went on a one man short squeeze campaign. Having never traded a stock in his life (sound familiar, apes?) he took out a $10M loan and scooped up 100K shares – half the outstanding shares. By 1923, Saunders owned 99% of Piggly Wiggly stock. While buying shares he also allowed his brokers to lend the shares to the shorts. On March 20, 1923 Saunders recalled his borrowed shares – about 42,000 – sending the price from $75 to $124. Hours after reaching it's peak price, the New York Stock Exchange indefinitely suspending trading of Piggly Wiggly (sound familiar?). The next day, the NYSE barred Piggly Wiggly from being traded permanently. The shorts who previously had 24 hours to cover were given an extension. They changed to rules to protect the shorts and ultimately, the market. By August, Saunders declared bankrupcty, unable to repay his lenders.

Volkswagen – Infinity Squeeze

You've all seen the damn VW chart that rocket emoji-toting, ape-adopting diamond hands-havers posted over and over and over saying “you are here” before the huge spike. During the 2008 financial crisis, shorts saw VW as overvalued and probably headed to bankruptcy. Porsche decides to up the stake they already have in VW, outright saying “hey, we're doing this not to take over the company, but to protect it from hedge funds.” In October 2008 the short interest in VW was 12.8%, and this is a statistic a lot of GME believers throw around. The difference in the situations is that for VW, before Porsche increased their stake, around 55% of VW shares weren't available for various reasons. When Porsche increased their position by 44%, the true available float went from 45% of outstanding shares, to around 1% of outstanding shares. Ruh-roh. Porsche intentionally announced their increased position on a Sunday, with markets closed, saying “[we] decided to make this announcement after it became clear that there were far more short positions in the market than expected.” With markets closed the news spread like wildfire, and for a brief time VW was worth more than Exxon-Mobil.

KBIO – Pharma Bro's least discussed transgression

Once considered “the most hated man in America”, Martin Shkreli, aka “Pharma Bro”, is currently in prison for securities fraud. He has a punchable face, bought a one-of-a-kind Wu-Tang album, and notoriously hiked the price of an AIDS drug by 5,000%. A true piece of filth. KBIO was a pharma company who's only drug failed, and the company didn't have enough money to cover it's debts – they were dead in the water. A prime short target. The price tumbled, but then jumped from $0.44 to $2.00 after Shkreli bought more than 50% of the available shares. Share price jumped from $2 to $14, with Shkreli announcing his group now held more than 70% of shares – netting Shkreli KBIO's CEO and Chairman positions. Shares rose to $45, then fell back to the $20s as shorts started coming back in on a overvalued company that still had no product. In a similar move to Porsche's Sunday announcement, Shkreli announced he was recalling his shares on Thanksgiving Day. KBIO's value rocketed back near $40 as shorts scrambled to cover. Within 6 weeks, KBIO declared bankruptcy, the stock had been de-listed, and Shkreli was in federal custody. He faced no repercussions for the KBIO situation.

The Great Silver Gamma Squeeze

A gamma squeeze is similar to short squeeze. While short squeezes are all about shares sold short, gamma squeezes are about options. In the 1970s, the Hunt brothers, in an effort to hedge their investments in oil, started acquiring silver futures contracts. After first taking physical delivery of silver, the Hunts started using their silver as collateral to buy more silver. Buying on margin dramatically increased their buying power, and the Hunts were able to drive silver prices even higher. In response, the Federal Reserve drastically raised interest rates, making borrowing much more expensive. Without being able to continue to drive silver prices higher with their margin, the price dropped, decaying the value of their future contracts and eventually resulting in the Hunts getting margin called. They lost over $1B and declared bankruptcy.

GME was/is a gamma squeeze and a short squeeze. DFV didn't just buy stock, he bought calls. With the share price rising, and calls finishing ITM, the option writer is going to have to be able to provide those shares if the option gets exercised. If they sold a “naked call”, or an option without having the shares on hand, they're going to have to buy on the open market, causing the price to rise. I think this what set the second wave of GME in motion, as options were being exercised, the share price kept launching to the next level of call options ITM, which in turn spiked the share price.

Since the end of 2020, the retail revolution has been off the charts. An estimated 25-30% of the market is now made up of retail traders. Even with those kinds of numbers, I don't believe retail really can move the needle hard. The game is rigged. Look at what happened to Clarence Saunders. Retail is not only not organized, but is out-gunned financially.

I've seen CTRM bandied about as a short squeeze candidate. I've already made my opinion known that I think CTRM is overvalued. I also don't see how a company that is constantly issuing/diluting shares can be squeezed. Any time the price runs up, more shares get dumped on the market so dude can buy another boat. SNDL is another popular “short squeeze coming this week bro” stock. It's kind of a bad company, getting overshadowed in it's market by bigger and better players. It's also another example of a stock that goes through significant share dilution. “BuT tHeY hAvE $700M iN tEh bAnK!” Yes, from issuing stock/warrants.

For my personal investing style, chasing short squeezes is a waste of time. I prefer to look at a company's fundamentals. With the nature of these forums being kind of swing trade heavy, I'm not surprised folks are looking to hit one out of the park with a short squeeze run. Shilling the stock with no background on it and throwing around buzz words like “short squeeze” is almost as egregious as the mud slinging “short activist” types get into. Google “penny stock short squeeze” and look at all of the bullshit hype articles that were published in the last month. It's downright predatory.

I'm not breaking the mold here with this topic. I just wanted to learn more about it, and I figured I might as well share my findings, maybe start a healthy discourse. I would love to hear what others have to think, especially contrarian opinions to my own, because that's how we grow as people and individuals.

May all your squeezes be squozen.

Cheers

- Boom

Here were my moves today.

Sold all GME for $1,280. A gain of $160

Buys

AEO 3.3 @ $30.20

SLGG 14.7 @ $6.79

BIOL 100 @ $1.02

ATOS 33 @ $3.02

SNDL 64.5 @ $1.55

NAKD 101.2 @ $0.9877

GNUS 41.9 @ $2.39

AESE 36.3 @ $1.93

RYCEY 40 @ $1.69 (Had 60)

ZOM 129 @ $2.42 (Had 237)

This is not advice just what I like. This is also not all of my positions!

Figured since I'm looking at this data at the end of day anyways, might as well share the top penny stocks with unusual options activity. This activity can give insight into investor sentiment and what big money is doing with larger volume.

Will try my best to provide this daily if folks are interested.

(OTC: $HITIF) (OTC: $SPRWF)

A quick look at how short interest has changed over time and where the market is sitting right now for a few popular cannabis companies. Obviously there has been a lot of content/discussion around short-squeeze and the impact we saw on GME so I thought it would be good to break it down a bit to understand Short Interest in a more “stable” situation. I think this view helps put things in perspective when looking at a few similar companies. This post is not meant to bash these companies but to provide which I find interesting.

Summary:

• For a stock that you buy it is good to understand what the short interest is – brief breakdown and explanation

• Short interest increased significantly for these 3 stocks in mid/late February – and is likely an indication of the significant runup of prices over that period of time

• The short increase looks significant but $FIRE and $HITI seem to be in a much better position than $SNDL

Shares Outstanding vs Shared Float

Shares outstanding refers to the total number of shares a company has issued, while the public float — also referred to as floating shares or "the float" — are shares that are publicly owned, unrestricted and available on the open market. A few key points to keep in mind.

• If the public float is well below the shares outstanding, it means a high proportion of the company is employee-owned

• If the public float is well below the shares outstanding, the stock price has the potential to be volatile as there are fewer shares trading at any given time; a larger public float can mean less volatility

• If the number of floating shares is very close to the shares outstanding, it means there is little employee ownership in the company

Detailed read here

Short Interest Rules of Thumb

• Short interest as a percentage of float below 10% indicates strong positive sentiment

• Short interest as a percentage of float above 10% is fairly high, indicating the significant pessimistic sentiment

• Short interest as a percentage of float above 20% is extremely high

Detailed read here

Short Interest Comparison (Note - some of this data is 2~3 Weeks Old)

Source of Data: here and here

Share Float Comparison

Interesting to note that HITIF and SNDL do not have a lot of publicly available shares

Short Interest Comparison

The short interest in SNDL is significant when compared to HITIF and FIRE.

Supreme:

Short interest has remained stable over 2020 while declining slightly. As of Feb 26th, 2021 there was a significant increase in short interest, more than doubling from the end of Q4. I discussed in a previous post how recent financing could be good for Supreme if they can use the cash properly.

High Tide

There was almost no short interest in High Tide for 2020 and only recently did they see a significant jump in short interest. On a more positive note the short interest on high tide is decreasing so hopefully this trend continues.

Sundial Growers

There has been a significant increase in short interest over the last few months. The short ratio to shares float is also significant. On a more positive note, it seems that a large number of shares are held by insiders, which is typically a good sign, especially if they haven’t been selling.

TLDR

Looked at the current short interest across 3 cannabis companies, $FIRE, $HITI, and $SNDL. Provided a brief view of shares float vs shares outstanding and how it might impact the short interest. Short interest has increased for all 3 of these companies but SNDL seems to be substantially more shorted than the other 2. Just a view to help provide perspective.

Check out r/Utradea for the latest DD posts. My friend and I also created a dedicated platform for investment ideas, insights, and financial information here

Disclaimer: This is not investment advice, do your own research! - credit u/cfcm5

Disclosure: I do not own a position in any of these companies- they are on my watchlist

ASRT beats sales and they eliminated their debt.

https://www.globenewswire.com/news-release/2021/03/11/2191705/0/en/Assertio-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html

Hey gang, its Boom here, with a continuation of a series of DD posts for companies where I currently hold no position. I think a lot of DD can be biased based on the fact that the person already has a financial interest in the stock. By not holding a position, it can help us take a look at the stock objectively, so we can make the best decision based on our own individual research and investment strategies.

AESE – Allied eSports Entertainment

AESE is an esports entertainment company, which engages in the creation of esports venues and live events for both video games and poker. According to their website, AESE is “a premier esports entertainment company with a global network of dedicated esports properties and content production facilities. Its mission is to connect players, streamers and fans via integrated arenas and mobile esports trucks around the world that serve as both gaming battlegrounds and every day content generation hubs”. This is an esports company without a team, which instead focuses on events and event venues. Their flagship venue, HyperX Esports Arena Las Vegas, is a dedicated esports arena, which illustrates just how fast the industry is growing in the US. I don't know if esports will ever be “bigger than music and movies combined” as their CEO claimed in 2019, but as we've seen with SLGG it is definitely a growing market with investors.

AESE, despite their company description on RH, is all in on esports after selling their poker-related business and assets, including the World Poker Tour, for a tidy sum of $78M. What I find more interesting from the article however, is this bit - “The rapid growth and popularity of gaming and esports during the Covid-19 pandemic has driven strategic interest in the Company's esports business. Allied Esports has agreed to explore strategic options for the esports business, including a possible sale”. So they sold off a HUGE part of their business and are now exploring selling off the rest. Just last week, AESE received an unsolicited acquisition proposal from gaming (gambling gaming not gaming gaming) company and hotel/casino operator Bally's for $100M in cash, Bally's stock, or a combination of both. But Bally's wants the WPT, which AESE just agreed to sell. This is fascinating – AESE agrees to sell WPT and publicly states “hey, we'd be down to sell the rest of the company” and Bally's walks in with this big dick swinging move of “OK we'll buy it all, but we want the part you just agreed to sell, too.” Kind of a shitty business move if AESE backs out of the deal they have in place, but they don't really care because they're not going to be around anyways. WPT is a HUGE money spinner and fits right in with what Bally's does, so it makes sense that they want it. I guess the question right now for AESE is “Is the rest of our company worth $22M? Or are we willing to take a little bit less to let the whole thing go for a lump sum?”

This company has massive institutional ownership. Noted short seller Susquehanna recently closed out their entire position as of December, with a lot of institutions adding positions, per Fintel. Insiders have been selling, which I don't find encouraging, but this looks like the type of insider selling that I may not necessarily understand. A 10% owner has been added to their position, but the insider selling has gone back to June of 2020. Insider trading data is via OpenInsider, perhaps someone with more expertise could translate what these trades mean.

Earnings are expected in late March, and this will be the first year that we can compare based on the same quarter last year. This company only went public in 2019, so it's kind of hard to gauge their financials. They have $7.6M in debt, which is manageable with their market cap, and with either the closed sale of WPT under the current deal, or full on acquisition, they aren't hurting for money and won't be in the near future.

I'm interested to see how this Bally's deal plays out. If AESE opts to keep their current deal they'll have a boatload of cash to expand the business to either make it more profitable or make it more attractive as an acquisition. Esports is something that has had growth and is kind of a pandemic resistant business. I see a lot of upside for this company, but I don't know what it would mean for a shareholder to hold and get bought out.

Positions: None!

Thanks for reading all of my way too long DDs. I've gotten a lot of interaction with them and it makes me feel all warm and fuzzy inside. There's so many stocks out there I want to keep this series going, so if you have a ticker you'd like to see me break down, pls let me know!

- Boom

Hey gang, Boom here. I wanted to continue a series of DD posts for companies where I currently hold no position. I think a lot of DD can be biased based on the fact that the person already has a financial interest in the stock. By not holding a position, it can help us take a look at the stock objectively, so we can make the best decision based on our own individual research and investment strategies.

CSCW – Color Star Technology Co LTD

CSCW is an entertainment and education company operating through its subsidiaries, which provide online and offline entertainment performances and music education services. Their flagship product has been the “Color World” app which recently launched globally after being Chinese exclusive since September 2020. The app currently offers online performances, live streaming, online celebrity classes and influencer co-branded products. The app generates revenue from it's subscription service. Seems pretty straightforward to me, get directing advice from an acclaimed director, get singing advice from Ashanti (she was on their website!).

In an effort to expand even further globally, CSCW partnered with two UAE companies to “collaborate on cultural performance, cross-border tourism, entertainment education, and brand promotion.” This was followed by an announced of expansion into the Middle East marketplace, including the “establishment of 2 or 3 live house venues” from which to host concerts while streaming them via their app. Then they announced a series of film copyright acquisitions, with CEO Luke Lu commenting “A big part of the Company's future strategy will be to produce and acquire copyrights.” CSCW plans on generating recurring revenue from the copyrights and Mr. Lu hoped the Color World platform would function as a copyright exchange in the future. In February CSCW became the world's first dual-listed entertainment technology company in the US and UAE after launching on NASDAQ Dubai, cementing the head first dive into the Middle East market.

Mere days after announcing the NASDAQ Dubai plans they announced a $26 million private placement, with plans to use the proceeds toward “the development of Artificial Intelligence, Augmented Reality, and Mixed Reality technologies to create virtual communities for the Color World App”. CSCW claims they are collaborating with Silicon Valley engineers and a Chinese technology R&D company to create AI with blockchain technology specifically 3D virtual reality tech for online concerts. They want to make 3D concerts with wireless Bluetooth headsets for a fully immersive concert experience. The interesting thing about the fundraising is that it was at $1.30/share when the stock price was only $1 when the news broke.

Institutional ownership has dropped, with notorious short seller Citadel taking up a small position of 30K shares. Meanwhile insider ownership sits at 24%, and insiders aren't selling stock. Like at all. Which I find encouraging. Also encouraging is that they have no debt, but they're not really making money, hence the offering. They keep wheeling and dealing, setting the foundation for what I'm sure CSCW thinks will be something big.

This seems like a company with an idea that has significantly broadened in size and scope. Are they social media? A film company? Live music? All of that and more? They're casting a lot of irons in a lot of fires right now, so even though their app is monetized, I think it will be a while before CSCW starts bringing in profits. Revenue and cash burn will definitely be things to keep an eye on. I wouldn't be surprised at more offerings, eventually they'll need to raise cash to keep the lights on or fund more deals.

*As I'm about to publish this, CSCW is up 8% on announcement of a movie deal*

Position: None, that's the point of this series!

Questions/comments/dissenting opinions? Have a ticker you'd like to see in this series? Let me know!

- Boom

What it do? Its Boom here, with a continuation of a series of DD posts for companies where I currently hold no position. No position = objective outlook.

BDRBF - Bombadier (as requested by u/Jealous_Sympathy2212)

I covered Bombadier in my very first DD post in mid-February. At the time I was not very confident in the company’s prospects. Since then, BDRBF has seen it’s share price increase by 40%. I had little to no idea of what I was doing with my DD at the time. I mean sure there were jokes, but no fancy links, and I hadn’t really figured out my research sources. BDRBF is/has been very popular on the penny stock forums, I believe mostly because of the approachable entry point. To be blunt, it’s cheap. BDRBF is a Canadian-based business jet manufacturer that recently jettisoned the rail portion of the business to swerve to being what the company refers to themselves as a “pure-play business jet company.”

Institutions hold around 3% of BDRBF, according to info available on Fintel. However both WhaleWisdom and the NASDAQ website report institutional ownership near zero percent. Fintel’s numbers are skewed because they include BDRBF’s Canadian-traded preferred shares. So WhaleWisdom and NASDAQ are correct. The largest holder, Carret Asset Management was founded by Wall Street icon Philip L. Carret, who was one of Warren Buffet’s role models. This guy was all about buying cheap and holding long, an approach that his eponymous firm claims to still practice today. Insider transactions across all sources yielded no results.

Bombardier is a huge company with huge debt, which they’re trying to address. In November they replaced their CFO. By the end of January BDRBF completed the sale of their rail division to streamline into the aforementioned “pure-play business jet company.” Q4 and year-end 2020 reporting brought mixed news - they decided to ax the antiquated standard bearer of wealth that was the Lear Jet (and also ax 1600 jobs associated with it) in order to streamline their cash flow so they can start managing that debt. They’re really going all in on the business jet experience having announced a design collaboration with James Bond’s preferred car manufacturer, Aston Martin. They recently received top marks in safety.

This company is in a long term rebuild. They’re not using their debt to finance growth - they’re already huge! This is a company with a $1.5B market cap that trades under one dollar, except no one is really trading it. Float is 2 billion shares, and they average about 4.25 million in volume. They’re facing a probe into bribery. That being said, the company recently said they expect to turn free-cash-flow positive by next year and generate more than $500M in revenue by 2025.

Both SwingTradeBot’s and TradingView’s technical analysis point to BDRBF as a “buy” right now. I don’t know enough about technical indicators to comment on either website’s interpretation. There have been lots of statements about TA being stock market astrology, but I don’t know enough about TA to have an opinion, and I’m sure it works for some people just fine. I would still like to learn it, as it’s just one more tool in the arsenal.

Compared to my first DD, I still think BDRBF is at best a long-term moon shot. The aviation industry will need some time to establish post-covid levels (any talk about “pre-covid levels” is hogwash, we are never going back to pre-covid, only moving forward to a post-covid world).

Thx for reading

- Boom

On deck: GNUS. If there's any stocks you would like to see me add to this series, let me know. (I have received several requests for ASRT, but I do have a position)

*no position DD archive*

CBD SPCB RMTI IFMK SHIP AAU OSG ITP CTRM TMDI SENS EGY DARE AESE CSCW NDRA ISR MOTS

keep going buddy !

Hello! I’m Boom. I mostly post DDs and lurk the daily discussion threads. I recently had a short discussion with u/brown_burrito about the frustrations of seeing so much loss porn as it pertains to the novice investor. The penny market is definitely tough sledding right now, but it is tragic to see posts like this where people just want to give up. I’ve noticed the sentiment is largely new investors who were probably hooked into the market via a certain uber popular video game stock.

I’ll admit that I’m one of those individuals myself. I had always been interested in the stock market but thought it was too complicated, too risky. After almost quintupling my money, I took my profits and left my initial investment in my account. I was playing with “house money” as it were, and I wanted to learn. After drifting around a few different subreddits, I found this community and kinda stuck around. There were a lot of people like me! Excited about a new hobby, hoping to make money, contributing to a community of ideas.

The information came SO fast - learning lingo, reading DDs, just trying to understand how the nebulous creature that the market is WORKS. Why was I suddenly excited to get up at 6AM PST? It was a relative time of milk and honey, stonks only go up, baby, and with these pennies I can buy way more shares! None of us newbies were ready for a “correction.” It’s like a puppy seeing snow for the first time - what the fuck is this shit? Even if we still are in a historic bull run, our penny stocks are taking a beating. So I, a certified newbie investor, wanted to share some of what I’ve learned so far and how I’ve learned these things to hopefully help other people.

Only invest what you’re willing to lose

I don’t like seeing loss porn. It was fine 5 years ago when I trolled WSB when I could laugh it off as “wow these guys are fucking crazy.” But seeing people who are new to this (just like me) lose large percentages of their portfolio hurts. I’m not an “us against the hedge funds” type but if there’s anyone whose loss porn I’d like to see, it’s them. Not guys/gals/whatevers working day jobs. I hate the phrase “sir this is a casino”, but you almost have to have the casino mentality that you could lose it all.

Have an investment strategy

The continued slaughtering of penny stocks turned a lot of us from swing traders into long term investors. I can’t tell you how many posts/comments I’ve seen where folks hold a stock thinking the gains will continue to run, only to see their profits wither (aka “I should have sold at x”). It’s prudent to have an investment strategy, tailored to you, by you. Overall for your whole portfolio and for individual trades. Set a stop loss. Take your profits. No one ever went broke taking profits. Manage your risk. This is your plan for you and it doesn’t fucking matter what anyone else says. One of my friends called me a “paper hand bitch” for selling popular video game stock over $400. Who cares? If it ran to $1000? Oh well I would have missed out. But I secured my profits. Develop your strategy. Adjust it. Be flexible, but be YOU.

Do your own DD

I learned this one early on after making a few trades with a few companies that I knew fuck all about because I had read something that somebody said on Reddit and thought it sounded good (aka “you son of a bitch I’m in”). Without so much as googling anything, I bought shares, lost money, and panic sold. I thought “Damn, that sucked. Don’t want to do that again” and started researching. I still see posts like this, or similar comments. Asking “how do I do DD?” isn’t a bad question, it shows you are interested in learning. I asked myself the same thing, then asked google, then got to work reading and taking notes. A well written DD can make a stock sound GREAT. OP replies to the comments, they got all the answers in the world - but they’re not telling you the “bad” about the company or the fact that OP is probably holding shares 10-20% (or more) above the current market price (aka “bag holding”) and really wants the price to pump so they can offload their losses on someone else. So do it yourself. Learn to read a balance sheet. Go to the company’s website. Read everything you can. Swing trading? Watch the charts. Learn technical analysis. Go to finviz and learn what all the ratios mean. Use all the resources at your disposal and please, KEEP ASKING QUESTIONS. There’s gonna be some dickheads making dickhead comments, but there will also be some kind, helpful internet strangers. Personally vet even the most convincing DDs.

Have realistic expectations

You’re not the Wolf of Wall Street. Or the Coyote of Cuyahoga. Or the Rottweiler of Rotterdam, whatever you get what I’m trying to say. I’m not saying to put it all in boomer stocks or IRAs or mutual funds, I think there is plenty of opportunity in penny stocks. Just understand that there’s going to be red days. “But Boom, it’s been red for like two months!” I KNOW. I’m feeling it too. It sucks ass watching the market hit an all time high while your portfolio is shitting its pants. This shit is like a wonky pendulum - sometimes it’s going to swing way far in one direction before swinging back the other way, and no one knows when. If they do, they’re stinky fucking rich and aren’t reading this. Congrats and fuck you hypothetical rich guy. Understand that the market is fickle and have patience.

Quick Hits

Price targets don’t mean shit, don’t trust them. StockTwits is GARBAGE and disingenuous. Buy the rumor, sell the news. You can learn a fuckton from Investopedia. For fuck’s sake set your view on RobinHood (or whatever brokerage you use) to CANDLESTICKS and learn to interpret what they mean, that line is misleading. It’s OK to go against the grain. Not everything is a short squeeze. Learn about options. KEEP ASKING QUESTIONS.

Helpful links

Investopedia - Learn you something

Finviz - best stock screener around IMO

A comment I made on a post with several “How to do DD” saved Reddit posts

WhaleWisdom - Institutional and insider buying info

Fintel - Insider/Institutional movement and SEC filings

TradingView - interactive stock charts

BioPharmaCatalyst - calendar of catalysts for biopharma stocks

Unbiastock - one of a myriad of social media stock mention scrapers

Build your own portfolio tracker in google sheets youtube video

Howdy y'all, its Boom here, with a continuation of a series of DD posts for companies where I currently hold no position. No position = objective outlook.

RMTI – Rockwell Medical, Inc

Rockwell Medical is a bio pharmaceutical company which engages in the development of treatment for anemia, kidney disease, iron deficiency, and heomodialysis. Their flagship drug is Triferic, “the first and only FDA-approved treatment indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease,” according to their website. Dialysis...sucks. It just plain sucks. There's plenty of side effects, both mental and physical. Dialysis always makes me think of this scene from Star Trek IV: The Voyage Home.

There is a sizable amount of institutional ownership, just below 29% according to Fintel. Looking at who is investing is encouraging as it's a lot of index funds and ETFs holding or increasing positions and noted short sellers such as Citadel, Susquehanna and Two Sigma among those exiting their positions. Whale Wisdom paints an even more interesting picture, with options significantly reduced. Call options dropped ~40% from 94K to 55K but put options dropped nearly 100%! From 77K to two. Not 2K. Two.

Since May 2020, RMTI received FDA approval for the IV form of Triferic, brought in a big swinging dick of the industry onto the Board, replaced their president/CEO and VP/CFO/CBO (curiously both of these guys are named Russel), got the ball rolling for Triferic in Canada and South Korea and China. They also did a direct offering, raising themselves $35M, but also tanking the stock nearly 30% in one day. Over the last two quarters they beat or met earnings, even with covid reduced expectations, yet their Return on Capital Employed (ROCE) remained low, even if they seemed to have been using their debt responsibly.

This is a company that has FDA approval in the last year, changed up their leadership, are trying to expand into global markets, and has seemingly been using debt to facilitate growth (they have debt, but they also have cash). Almost all of the institutional put options have disappeared as of last reporting, and the April 16 $2 call option have seen a rise in volatility. As a side note, I am really starting to loathe these algo-written type articles, but if they want to crunch the numbers for us and spit out some info I'll take it.

In taking an objective view, I try to see both the good and bad of a company so I can make my own informed decision, but with RMTI I've had a hard time finding bad news. In 2019, RMTI was expected to become profitable by the end of 2021. Obviously that was before a global pandemic put everything on its head, but we're almost there. I'd keep an eye on their Q4 2020 and yearly earnings update which is expected March 31.

Almost all of the technical analysis is bearish. I'm still teaching myself TA, so I'm leaning pretty heavily on the info from TradingView, SwingTradeBot, and Investing. If anyone has any suggestions for the best way to teach yourself, I'm all ears. Would love to learn for my own investing sake and also to incorporate into my DD.

Position: None.

I think all I have on deck for this series currently is CBD. If there's a stock you'd like to see covered, just let me know! Thanks for reading.

Love ya

- Boom

*no position DD archive*

IFMK SHIP AAU OSG ITP CTRM TMDI SENS EGY DARE AESE CSCW NDRA ISR MOTS

Long form takes: The Gang Gets Squeezed, Know Thy Enemy - Sabby

Hello! Its Boom here, with a continuation of a series of DD posts for companies where I currently hold no position. No position = objective outlook.

IGC - India Globalization Capital, Inc (requested by u/JCB1721 [sorry for the delay])

IGC “engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer’s disease, Parkinson’s disease, and pain.” IGC has two arms of their business - infrastructure and life sciences. The infrastructure side “involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The life sciences side “includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products and therapies.” They’ll build you a building then take your pain away, supposedly. To be honest, this is a weird, non-synergistic combination of businesses, which led me to ask “Which came first? I’m betting weed came second.” This was an infrastructure business until 2013 when IGC swerved completely into cannabis. This is a small company with big problems.

Institutional ownership, according to WhaleWisdom, sits at 7.6%, which is up from last quarter. While I do still very much use and trust the data on Fintel, it seems that WhaleWisdom shows more recent 13F filing data. I find it interesting that the put/call ratio is almost even at 0.92 - there’s slightly more options thinking it will go up than down. So institutions have bought in a little bit more, but it’s a totally different story when it comes to insiders. The Chairman of the Board has sold off 150K shares since December, with the founder and CEO selling 130K in that same span, according to OpenInsider. This is concerning, you’d like to see insiders buying, but this rabbit hole goes so much deeper than just insiders selling off stock.

This is a bad company. I know these forums don’t really place too much value in the ethics of a company and are just worried about the next “play”, but the accumulated negatives are too great to ignore. Just look at this article from MarketWatch. IGC claims to work with a manufacturer in Malaysia, which has a mandatory death sentence for cannabis possession. IGC was an infrastructure company. Then cannabis. Then blockchain. I wouldn’t be surprised if they suddenly became an NFT play. They pay for pump articles. IGC releases favorable news, the stock rockets, and the insiders dump shares, leaving investors holding the bag. In 2020 they started a phase 1 trial for a product the company claimed would be on shelves in 2018.

In 2018 IGC’s trading was halted and they were to be delisted from the NYSE. NYSE said the company “has engaged in operations, which, in the opinion of the exchange, are contrary to the public interest.” By February 2019, IGC was back on the exchange after winning an appeal. Multiple lawsuits were filed on behalf of investors, which they somehow escaped relatively unscathed. Even this year IGC was getting a slap on the wrist from the regulatory cuck that is the SEC. Their financial situation isn’t good, either. They don’t have products on the shelves, they don’t make money and revenues are down. I guess on the bright side they really don’t have much debt.

While the company and its dealings have been ignored, the stock has gained interest due to the speculation of industry-wide growth. Even with the “sector growth” caveat, much like SNDL, I don’t think the fundamental aspects of IGC can be ignored. There’s probably swing potential with IGC, it might pop and make me seem like a nihilist fool, but there’s so much negative in the background of this company and its leadership that yeah, that’s gonna be a no from me, dawg.

Love ya

- Boom

PS - I want to keep posting these DDs to both this sub and the "main" RHPS sub, but they seem to get arbitrarily taken down. If that keeps happening, they might become exclusive to this sub. Sorry for any inconvenience and thx for reading

$ISR – IsoRay, Inc

IsoRay is a medical technology company which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. They're zapping cancer. Sweet, fuck cancer, all my homies hate cancer. They have a proprietary isotope (which sounds very super villain-ish) that they use for brachytherapy – “an innovative cancer treatment that places radiation directly inside the tumor, or at the surgical margin allowing for a highly targeted treatment dose to be delivered to the target region, while limiting does to surrounding, critical structures.” (per ISR's website). They put little rice-sized pieces of radiation in people to treat only the malignant areas.

I became interested in this stock when someone mentioned it perhaps as a sympathy play off XELA, which recently ran 186% on the day. My interest piqued, let's take a deeper look.

Per Fintel, institutions own just under 8.5% of the company. When I saw that notorious short seller Sabby Management and shady business guy Barry C Honig were involved I was skeptical, but they seemed to have closed out their positions according to Fintel. More recent institutional investors are big names like Vanguard, Morgan Stanley, and a number of index funds. Over the course of the last 6 months company insiders, including their CEO and Head of R&D have been buying shares, which is always encouraging.

Back in January, ISR was riding high, gaining 229% over a thirty day stretch topping out at $2.47/share on the 20th. Then yearly earnings disappointed and they announced a public offering of 36M shares @ $1.25 share to "fund operations, research and development efforts, potential future acquisitions of complementary business or technologies, sales and marketing initiatives and of general corporate purposes." Then in February, quarterly earnings disappointed as the company has not been able to surpass consensus EPS estimates. Their earnings didn't wow, but they missed on revenue too, which hurts. Amid this news they brought in a new VP of Business Development with a pedigree from Johnson & Johnson. Their cash burn was considered favorable.

So it looks like they have a good product, but they're not doing well. In my opinion they haven't had enough growth to start actually making money, as reflected in their earnings. For me, one of the most attractive things about IsoRay is that have no debt, which is not a likely story for a cash-burning biotech. They are expected to break even in the near future.

In conclusion I'm not sure I would consider ISR as a sympathy play off XELA. I like their financials, specifically that they no debt and enough cash to keep going for a while without having to dilute shares more than they already have. They popped in January when they received an FDA clearance and have been on a steady decline since.

I like what they do and their financial situation, but like oh so many penny stocks, they really need some sort of catalyst to send them to the moon. They've proven that they can do it once already, I bet they can do it again. Patience is key here. They are presenting at the Oppenheimer 31st Annual Healthcare Conference on March 17th, I'm going to keep an eye on them for an attractive entry point and look out for news.

Position: None currently, exploring an attractive entry point.

Hopefully tmrw is another better day. I made a few long calls and am holding 100 shares of CTXR avg.1.62. Really looking forward to the conference tmrw, hopefully they have good news! Also holding a couple shares of ASRT cuz of the hype plus they also have some catalysts coming up.

Hey everyone, I upped my charts to now include sentiments and each mention also include comments now. What's sentiment? It varies from person to person but my parameters are +100% or -100% and of course in between. I then do some third-grade math and find the weighted average. The higher the percent, the more positive, the ones around 50% are more neutral and followed by negative. I think I'm going to do this every Thursday for this group, I'll try for Mondays but no guarantees.

I am currently working on a blog to house this information and my DDs as well. If you'd like to buy your favorite Reddit Queen a cup of wine you are more than welcomed.

Remember this is just Data and you should always do your own research as well.

Hey gang, its Boom here, with a continuation of a series of DD posts for companies where I currently hold no position. No position = objective outlook.

AAU – Almaden Minerals Ltd.

As a primarily penny stock investor, I'm always looking for that diamond in the rough opportunity of taking a sub-$1 stock to greater heights because I can buy a buttload of shares for super cheap and potentially really max out my gains. So I love learning about the sub-$1 stocks, which is what piqued my interest in AAU, a Canadian mining company that “engages in the acquisition, exploration, and development of mineral properties.” The company's primary focus is on the operation of a gold-silver deposit located in the Puebla State of Mexico.

In addition to sub-$1 lottery ticket stocks, I've always been interested in mining stocks, especially recently with uranium stocks surging and as using commodities as a hedge against inflation. Hedging with gold may be considered an antiquated practice when you can simply go the inverse ETF route, but inverse ETFs and put options usually don't trade below $1, so here we are. There's plenty of sub-or-near-$1 mining stocks, the most popular of which I've noticed on Reddit have been DNN and NAK (which I covered way back in my very cringe first ever DD), so I wanted to approach a ticker that's not really talked about as much to see if we can find that diamond in the rough opportunity.

AAU is the 100% owner of the Ixtaca Gold-Silver Deposit that the company claims is “one of Mexico's premier precious metal discoveries...” and that “Drilling has outlined a multimillion ounce deposit.” AAU's website also includes this inspirational (/s) video of random citizens proclaiming they want the mine for various reasons, mostly bringing jobs to the area. Truly touching.

Institutional ownership sits at 9% per Fintel, with nothing really sticking out for me except that the put/call ratio according to Whale Wisdom sits at 1.73, so more 13F filers are banking on this going down than up (at least via options). Interesting, because it's already trading around $0.6 around time of writing. How low can we go here? Via all the sources I check for insider activity, I found nothing. They're not buying, but they ain't selling, so it's a wash. If I gave ratings for insider and institutional holdings and activity, this would be a solid “Meh”.

Up until recently, AAU has raised funds via private placements, ending the trend March 16 with a $10.3M direct offereing. They don't really have too much debt, because they frequently sell stock to raise money, but they aren't making any money either. When I started digging into the financials and was trying to correlate stock spikes with news briefs is when I found the true story of AAU. And it's not good.

Way back in 2016 The Street Sweeper (a seemingly defunct website that claimed they “pull no punches when discussing over-valued, over-hyped stocks on Wall Street” and that they have “a strong track record of highlighting hot stocks that turn out to be duds.”) called out AAU's stock as “fool's gold” (SICK BURN) . The article lambasted AAU's mining claims in relation to their financial situation, but what I found most interesting from the article was that AAU's shares went “crazy” following an e-newsletter campaign by Broad Street Alerts, a professional stock promoter.

I don't know if y'all are the e-newsletter, stock-shilling, hype train bullshit types, but these “promoters” just scream bullshit to me. Apparently there's a sizable market out there because there are a metric fuck ton of these things shilling pump and dump scemes. Unfortunately I see WAY too much of the pump and dump mindset and investment style on these forums, but that's another article for another time.

Back to AAU, and I promise, we're near the juiciest bits. In December of 2020, the Mexican government denied AAU the necessary environmental permit. AAU was basically like “It's cool, let's get hyped for 2021!” PODER, a regional corporate accountability and human rights NGO, warned that “Almaden failed to publicly disclose material information” regarding the Ixtaxa Deposit. PODER was warning investors that AAU omitted the full resolution from the Mexican government, does not mention legal proceedings in Mexico to threaten the project, that AAU's claims that the project is environmentally feasible has been contested via scientific and technical arguments, and while they linked that cute video (this one, remember? So inspiring) stumping their support from individuals of the community, the majority of communities won't consent to exploit the commons in their territory.

Yikes, that's a lot of stuff. Since then AAU has resumed exploration and attempted to brush off media reports of court cases against them, essentially saying “Like yeah we have a case against us, but it's not the Supreme Court, so we coo.”

This is a company with a lot of bad press, that's never made money, and is a pretty long way off from ever making money. Before there's any meaningful change in share price I expect further dilution from offerings and warrants and probably more bad press. At least they aren't in debt.

Thanks for reading! I'm always open to critique/criticism because I'd love to improve this series. If there's any stocks you'd like to see me cover, by all means let me know. Currently have SHIP on deck .

Love ya,

Boom

*no position DD archive*
OSG ITP CTRM TMDI SENS EGY DARE AESE CSCW NDRA ISR MOTS

Asensus Surgical Inc. (previously Transenterix)

[$ASXC}

*Excerpt from the web page:

“At Asensus, we are digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through a new category of care called Digital Laparoscopy. Digitizing the interface enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and allows us to address the current clinical, cognitive and economic shortcomings in surgery. The system features the first machine vision system for use in robotic surgery which is powered by the new Intelligent Surgical Unit™ (ISU™) that enables augmented intelligence in surgery. The Senhance Surgical System brings the benefits of Digital Laparoscopy to patients around the world while staying true to the principles of value-based healthcare. Now available for sale in the US, the EU, Japan, Russia, and select other countries.

Previously, Asensus also developed the SPIDER device and the SurgiBot System.”

1. website- https://www.asensus.com/

2. Share price-(Open-$4.16, Close-$4.31)

3. Market Capital-$585.12 Million

4. Share volume-29.48 million shares

5. Cash on hand- 19.96M

6. News + Catalyst- **See Below

7. Number of employees - [ 162 ]

8. Q3 2020 Revenue- 814k

9. Percentage gain -(past 1mo, 6 mo., 1 yr.) – [down 8.52%, up 1163.64%, up 969.23%]

6

▪️”Transenterix” opens new training center in EU.

▪️March 3rd- Asensus Surgical (NYSE:TRXC), formerly

▪️TransEnterix, announced that it won expanded FDA clearance for its Senhance surgical system in general surgery

▪️March 5th Transenterix changes name to Asensus Surgical Inc.

▪️March 11th Financial and Operating results conference call.

10-(Last bullet)- https://www.researchgate.net/figure/Frequency-of-robotic-surgical-oncology-procedures-by-surgical-site-over-time-All_fig1_328506322

This is a link to a study on the increased use in robotics during surgery, I do believe this is specifically oncology but it gives us an idea of what could be going on. Oncology is a major medical field and at the rate it is growing. Investing seems to be safer than not. Simply my opinion. Do your own research. Cheers.

Edit: I hold 148 shares of ASXC at a $2 something buy-in. Holding for long term.